CA19-9 for detecting recurrence of pancreatic cancer

CA19-9 values are regularly measured in patients with pancreatic cancer. Certainly, its potential as a biomarker has been compromised by false negative results in CA19-9 negative patients and false positive results in benign pancreatico-biliary diseases. For detection of PDAC recurrence, however, CA...

Descripción completa

Detalles Bibliográficos
Autores principales: Azizian, Azadeh, Rühlmann, Felix, Krause, Tanja, Bernhardt, Markus, Jo, Peter, König, Alexander, Kleiß, Mathias, Leha, Andreas, Ghadimi, Michael, Gaedcke, Jochen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987233/
https://www.ncbi.nlm.nih.gov/pubmed/31992753
http://dx.doi.org/10.1038/s41598-020-57930-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987233/
https://www.ncbi.nlm.nih.gov/pubmed/31992753
http://dx.doi.org/10.1038/s41598-020-57930-x

Ejemplares similares